Challenger

Challenger
CME and Preparatory ProductsProgramsWeb ProductsReviewsTech SupportFrequently Asked Questions


Quick Quiz Newsletter
Compliments of Challenger Corporation

Click image to enlarge






Med-Challenger PEDS
Comprehensive Review and Assessment for Pediatricians
Emergency Physicians


For more information on Challenger's boards preparation, clinical review, and other electronic resources for physicians, visit www.chall.com, or call a Challenger Sales Representative at
1-800-676-0822, ext. 4400.

Try Our Products!
Click Here for a Free Demonstration
.

Issue: October 15, 2007
Case:
Immunologic and Rheumatologic Diseases
Taken from
Med-Challenger PEDS
All Products | Challenger Corporation
Click Here for a Free Product Demonstration.

Question:

A 9-year-old boy presents with a rash. The rash began as a macular papular rash, but it has now evolved into the rash seen here. The child also has a swollen ankle without history of trauma, and he complains that it is quite tender (see illustrations to right). He has complained to his parents of vague abdominal pain over the past 2 days.

What lab study is it important to follow acutely as well as over the next 4-6 weeks?
 
  1. erythrocyte sedimentation rate
  2. neutrophil count
  3. urinanalysis
  4. platelet count
  5. none

Answer:
Click here for the answer and clinical remediation.

    Win a $500 Educational Grant!
    Write a Question and Answer for ANY Challenger Educational Course. If our Physicians Advisory Board selects YOUR question at their semiannual meeting, you'll receive a $500 educational grant.

    All submissions become the intellectual property of Challenger Corporation but you'll receive author credit for the Question and Answer in our next release. VIEW DETAILS HERE.

    View past newsletters here.


    If you received this newsletter from a friend, Click here to receive your own Quick Quiz Newsletter.

    Compliments of Challenger Corporation
    5100 Poplar Avenue, Ste. 1410
    Memphis, TN 38137


    Copyright (C) Challenger Corporation. All rights reserved.